Tocilizumab
Tocilizumab is a humanized monoclonal antibody against the interleukin-6 receptor. It is used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis. In Japan, it is also approved for Castleman’s disease, a rare benign tumor of B cells.
